logo
How do Front-of-Package Warnings Influence People?

How do Front-of-Package Warnings Influence People?

Medscapea day ago
One of the most common arguments put forth against front-of-package label reforms and warnings meant to help fight obesity is that enacting them will exacerbate weight bias and stigmatization.
A recent randomized study set out to look at the impact four different types of front-of-package label warnings on sugar-sweetened beverages had on perceived weight stigmatization and attributional judgments of responsibility for weight and explicit weight bias. The different label types were nutrient warnings indicating a beverage was high in calories or added sugars, text-only health warnings, or graphic health warnings indicating the beverages were linked to obesity, diabetes, and tooth decay. The labels also differed on whether the content referenced calories and obesity or not.
Bottom line findings are easy to describe and not particularly surprising. Labels that referenced obesity as a risk were perceived to be more weight stigmatizing than those that did not, while labels that focused solely on nutrients had a lower perceived efficacy — but only slightly.
However, there's still a bit to unpack regarding this study's outcomes and utility. Most important, and as acknowledged by the authors, is that this study did not measure the actual impact of these labels' long-term repetitive use but rather simply studied participants' conscious perceptions after a singular, nonorganic exposure. While some might presume that longer term repetitive shopping exposure would amplify all effects, it's also plausible that long-term exposure will see effects dissipate as consumers become inured to the messaging.
But it was heartening to read that nutrient only front-of-package warnings were found to be nearly as plausibly effective as those specifically linked to obesity, because the consumption of sugar-sweetened beverages is something that should be minimized regardless of the weight of the person drinking them. The same of course is true for any food or nutrient of concern as weight does not dictate whether something is or is not healthful or risky to consume.
It is also worth remembering that front-of-package warnings are just one deployable strategy vs the flood of unhealthy food and predatory marketing, and that the more sandbags we fill, the greater the likelihood of benefit. Looking to front-of-packages specifically, along with warnings we might layer on health claim reforms which could, for instance, prevent a box of Froot Loops from bragging on its front that it is fortified with Vitamin D. We might also look to the banning of cartoon mascots designed to entice children and to laws around advertising as a whole in terms of what and when unhealthy food advertising is permitted.
Back to this study, though: If the goal as implied is to reduce the consumption of sugar-sweetened beverages, specifically as a sandbag vs societal weight gain, an additional question to ask is whether the impact these same labels might differ between consumers who are and are not utilizing obesity medications.
The impact of a warning meant to change food purchases might be influenced by a consumer's degree of hunger and cravings and where those are reduced dramatically by obesity medications. This hypothesis is markedly strengthened by the fact that, even without front-of-package labeling changes and reforms GLP-1 users' purchases have been shown to skew away from calorie-dense, ultra-processed items and towards more healthful items.
And if it is found that, yes, people on GLP-1 medications purchasing behaviors are more strongly influenced by labeling reforms and changes than non-users; that observation supports both the implementation of these sorts of reforms (as more and more people with obesity begin to utilize medications, perhaps especially given their coming genericization) and for their formalized coverage through Medicare and/or government interventions designed to help reduce their price.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

President Trump's "big, beautiful bill" threatens Medicaid access for millions in Florida, advocates warn
President Trump's "big, beautiful bill" threatens Medicaid access for millions in Florida, advocates warn

CBS News

timean hour ago

  • CBS News

President Trump's "big, beautiful bill" threatens Medicaid access for millions in Florida, advocates warn

Millions of Floridians could lose access to life-saving Medicaid coverage under a new legislation that slashes billions of dollars in federal funding, health advocates warn. The Florida Health Justice Project estimates the legislation will cut about $4 billion annually in federal Medicaid support to the state, impacting at least one million current recipients. While it's unclear exactly who will lose coverage, advocates say the most vulnerable populations — including elderly residents who rely on Medicaid to help pay for Medicare premiums and legal immigrants with temporary status — will be among the first affected. "There's really just one step away from sheer panic," said Lynn Hearn of the Florida Health Justice Project. "If you have a person with a severe disability, they are relying upon the services of Medicaid literally to stay alive." In Florida, roughly four million low-income individuals or people with disabilities depend on Medicaid, the government-funded health insurance program. Florida residents with disabilities fear tighter Medicaid restrictions Paolo Linares, a Liberty City resident, is among them. Diagnosed with autism and ADHD, she lives at home but was hoping to gain independence by moving out. She said the new restrictions could make Medicaid inaccessible when she needs it most. "This type of paperwork may make it harder in the case that I may need it," Linares said. "If you're going to put more stricter things on this, what are you going to do to help these people?" Clinics may close as Medicaid cuts ripple through Florida's health system The ripple effects could reach beyond Medicaid recipients. Hearn said as fewer people are able to seek care, medical providers may not be able to stay in business — affecting access for even those who remain insured. "When there aren't as many people who are insured and able to go to the doctor and get services, then those service providers aren't able to maintain their business," she said. "And then they shut down." Among those expected to lose coverage are refugees, asylum seekers, parolees, and others from countries like Afghanistan and Syria who are in the U.S. legally but lack permanent resident status. "These are people who have been able to get coverage for their families, but that will end," Hearn said. She added that the next state budget cycle will likely force Florida to make tough choices about what Medicaid benefits to continue funding. For now, the Florida Health Justice Project said it will focus efforts on lobbying state lawmakers to secure alternative funding for the program.

Deadly opioid carfentanil reemerges in Michigan, linked to 11 deaths in 2025
Deadly opioid carfentanil reemerges in Michigan, linked to 11 deaths in 2025

CBS News

timean hour ago

  • CBS News

Deadly opioid carfentanil reemerges in Michigan, linked to 11 deaths in 2025

Michigan health officials say the state is seeing a reemergence of the potentially deadly opioid carfentanil. Carfentanil is a synthetic opioid, typically used by veterinarians to tranquilize large animals, like elephants, and is not approved for use in humans. State health officials say that so far this year, 11 deaths involving carfentanil have been identified. None of those individuals tested positive for carfentanil alone. Ten of those who died also tested for cocaine, and fentanyl was found in eight of those deaths. The deaths occurred in Ingham, Livingston, Eaton, Genesee, Oakland and Wayne counties. The synthetic drug is a small, white, powdery substance that looks like cocaine or heroin, but officials with the Drug Enforcement Administration say that using even a small amount could kill. "Imagine like a speck of baby powder; that's how much could be a lethal dosage of carfentanil," said Brian McNeal, public information officer with the DEA's Detroit division. "It is a Schedule II drug, meaning it does have medical use, but it is not approved for human use, and it has found its way into the illicit drug supply." Carfentanil is 100 times more potent than fentanyl and about 10,000 times more potent than morphine, according to the Michigan Department of Health and Human Services. "Carfentanil is an extremely potent and deadly drug," said Dr. Natasha Bagdasarian, Chief Medical Executive for the State of Michigan. "We're urging people who use unregulated drugs – and their loved ones – to carry naloxone, an easy to administer nasal spray that can reverse opioid overdoses and save lives. Awareness and quick action can help save lives." The DEA says some users mix carfentanil with other drugs like OxyContin or Xanax. "Whether it's heroin, marijuana, or cocaine, it follows the same routes up from our southwest border into distribution hub, like any other business, and then into smaller communities and neighborhood, but the precursor chemicals mainly come from Asia, from China, India into Mexico, where drug cartels are putting these chemicals into the illicit drug supply," McNeal said. Carfentanil was previously seen in the state in 2016 and 2017, with the drug contributing to 107 deaths in 2016 and 111 deaths in 2017. Deaths associated with the drug fell in recent years, dropping to a handful a year in 2018, 2019 and 2020, and then to zero in 2021 and 2022. Health officials say the drug can rapidly cause central nervous system depression, which can lead to quick death, and that because an increasing number of overdose deaths associated with carfentanil also include cocaine, methamphetamine and other stimulants, users may not know those drugs contain carfentanil. Treating a carfentanil overdose can also be extremely difficult, and officials say reversing an overdose may require several doses of naloxone.

US Probiotics Market Poised for Strong Growth Amid Surging Demand for Digestive Health Solutions
US Probiotics Market Poised for Strong Growth Amid Surging Demand for Digestive Health Solutions

Yahoo

timean hour ago

  • Yahoo

US Probiotics Market Poised for Strong Growth Amid Surging Demand for Digestive Health Solutions

Delray Beach, FL, July 02, 2025 (GLOBE NEWSWIRE) -- A new research report, 'US Probiotics Market by Ingredient (Bacteria and Yeast), Product Type (Functional Food & Beverages, Dietary Supplements, and Feed), End User (Human and Animal), Distribution Channel, and Region', highlights robust growth in the US probiotics market. The market is booming as consumers increasingly recognize the vital connection between gut health and overall well-being. Get PDF Brochure Now: Digestive Health Awareness Fuels Market Boom A wave of digestive health awareness is sweeping the nation, driven by interest in preventive care, natural wellness solutions, and healthy aging. Americans are turning to probiotics from yogurts and supplements to kombucha and snacks — to support gastrointestinal health and manage conditions like IBS and IBD. Regional Hotspots: California, New York, Texas Lead the Probiotic Revolution Regional trends show California, New York, and Texas at the forefront of probiotic consumption, fueled by their diverse, health-focused populations and dynamic retail and Innovative Products Meet Growing Demand From functional foods and drinks to skincare and beauty applications, the US probiotics industry offers consumers an ever‑expanding selection of probiotic‑enriched products designed to fit modern lifestyles. Today, probiotics are available across a wide range of categories, making it easier than ever for people to integrate gut‑friendly benefits into their daily routine. These products include: Yogurt and Kefir: The traditional staples of probiotic nutrition. Kombucha and Functional Beverages: Refreshing drinks packed with gut‑friendly bacteria. Dietary Supplements: Capsules, powders, and gummies with targeted probiotic strains. Snacks and Nutrition Bars: Convenient options for on‑the‑go probiotic support. Skincare and Beauty Products: New formulations that harness the benefits of probiotics for skin health and microbiome balance. Personalized Nutrition Solutions: Tailored probiotic supplements based on individual microbiome profiles. Explore Growth Opportunities in the Booming US Probiotics Market Strong Endorsement from Research and Surveys The 2022 IFIC Food and Health Survey found that around one-third of Americans try to consume probiotics, with nearly 60% doing so daily. This reflects shifting preferences toward natural, functional ingredients amid rising rates of obesity and micronutrient deficiencies. Industry Leaders Drive Awareness and Innovation Powerhouse brands like ADM (US), International Flavors & Fragrances Inc. (US), BioGaia (Sweden), Lifeway Foods, Inc. (US), Winclove Probiotics (US), and Lallemand (Canada) are at the forefront, investing in consumer education, marketing, and product development to meet growing demand. The Road Ahead for the US Probiotics Market As probiotics go mainstream, the US market is poised for continued expansion, driven by advances in microbiome research, personalized nutrition, and cross-industry collaborations. As Americans continue to prioritize their well‑being and seek natural alternatives for health maintenance, probiotics are poised for long‑term growth. The trend goes beyond consumer preference; it signifies a shift towards a more mindful approach to nutrition and a holistic understanding of how gut health influences immunity, mood, and overall quality of life. With advances in microbiome science and the growing role of personalized nutrition, the US probiotics market is expected to evolve even further — opening new opportunities for innovation and making probiotic-rich products an integral part of daily life. Key Questions Addressed by US Probiotics Market Report What is driving the growth of the probiotics market in the US? What are the most popular probiotic products in the US? Which US states have the highest demand for probiotic products? What health conditions are probiotics most used for in the US? Are probiotics gaining popularity beyond supplements? Who are the leading brands in the US probiotics market? What is the future outlook for the probiotics market in the US? What are the key product types considered in the study for Probiotics, and which segments within Asia Pacific's Functional Food & Beverages product type are projected to experience promising growth? Is there customizable information available specific to the North America Feed market within the Probiotics study, and if so, what details are provided? Could you highlight the opportunities identified in the study that are expected to fuel the future growth of the Probiotics market? Among the regions studied, which one is anticipated to exhibit the CAGR for the Probiotics market? What is the market trend for probiotics? How big is the probiotics market? Why are probiotics so popular now? What is the probiotic industry? What is the market outlook for probiotics? What will happen with probiotics in future? Who is the target market for probiotics? Does the FDA regulate probiotics? Are probiotics a trend? What is the probiotic market forecast? What is the price prediction for Flora growth? What is the trend in probiotics drinks? What are next generation probiotics? What are next generation probiotics FDA? CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@ Visit Our Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store